Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL7601322 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL854955 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL6383668 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL6036466 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL17555384 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL4453244 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL8505699 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL6393520 | 0.96 | CA2 (0.40) | — | |
| Phosphoric Acid SCHEMBL4138989 | 0.96 | CA2 (0.40) | — | |
| Phosphoric Acid SCHEMBL11300975 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2429 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119959428-A | Quality control method of melagatran besylate | 江苏正济药业股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119619349-A | Liquid chromatography detection method for related substances in esmolol hydrochloride injection | 华夏生生药业(北京)有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-115856122-B | Method for simultaneously detecting components of multiple drugs in Yu Huang oral liquid by adopting UPLC-PDA | 山东省饲料兽药质量检验中心 | 2025-02-28 | — | — | CN | claimed |
| CN-119534706-A | Quality detection method of diclofenac sodium lidocaine hydrochloride injection | 四川健林药业有限责任公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119246732-A | Isolation and measurement of calcitriol intermediate Z2Method for impurity DMP | 重庆华邦胜凯制药有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-111650290-B | Analysis method of related substances of tenofovir alafenamide hemifumarate | 江苏艾立康医药科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-119104632-A | Method for detecting acarbose medicine related substances | 上海现代制药股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-119086792-A | Quality detection method of nalmefene hydrochloride injection | 四川健林药业有限责任公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118914389-A | Detection method for nitrosamine impurity NTTP in sitagliptin phosphate tablet | 江西施美药业股份有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118795062-A | Content determination method of epalrestat bulk drug | 泰州越洋医药开发有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-1915223-A | Chewing tablet of compound aluminum magnesium hydroxide, preparation method and method for measuring quality | ZHENGXIN MEDICINE RES CO LTD L (CN) | 2007-02-21 | — | — | CN | claimed |
| CN-1285907-C | Tanshinone II A sodium sulfonate and method of determining tanshinone I sodium sulfonate in its preparation | JINAN BAINUO MEDICINE SCIENCE (CN) | 2006-11-22 | — | — | CN | claimed |
| CN-1847843-A | Method of measuring ginsenoside Rb1 content in Chinese medicine | TIANJIN TIANSHILI PHARMACEUTIC (CN) | 2006-10-18 | — | — | CN | claimed |
| CN-1724025-A | Method for controlling quality of injection liquid or powder of | YU WENYONG (CN) | 2006-01-25 | — | — | CN | claimed |
| CN-1679871-A | Quality control of compound Danshen root drops | TIANSHILI PHARM CO LTD (CN) | 2005-10-12 | — | — | CN | claimed |
| CN-1670524-A | Method for measuring fingerprint pattern of compound salvia dropping pills | TIANJIN TASLY PHARMACEUTICAL (CN) | 2005-09-21 | — | — | CN | claimed |
| CN-1624474-A | Tanshinone II A sodium sulfonate and method of determining tanshinone I sodium sulfonate in its preparation | JINAN BAINUO MEDICINE SCIENCE (CN) | 2005-06-08 | — | — | CN | claimed |
| CN-1440773-A | Preparation method and quality control method of QINGKAILING injection or injectable powder | YU WENYONG (CN) | 2003-09-10 | — | — | CN | claimed |
| EP-0675900-B1 | ANTIBIOTICS GE 37468 A, B AND C | BIOSEARCH ITALIA SPA (IT) | 1998-02-18 | — | — | EP | claimed |
| EP-0359062-B1 | Antibiotic GE 2270 | LEPETIT SPA (IT) | 1994-02-16 | — | — | EP | claimed |